Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0027982 ANTICOAGULANT AND DECOAGULANT METHODS, COMPOSITIONS AND DEVICES
Disclosed are anticoagulant and decoagulant methods, compositions and devices comprising calcium carbonate, particularly, comprising aragonite.
2017/0027981 CARRIER STATUS OF ANNEXIN A5 M2 HAPLOTYPE AND OBSTETRIC RISKS
The present invention relates to determining the carrier status of Annexin A5 M2 haplotype of parents (both male and female) prior to and/or after pregnancy to...
2017/0027980 COMPOSITION BASED ON XYLOGLUCAN AND PROTEINS FOR THE TREATMENT OF INTESTINAL DISORDERS
Disclosed are compositions comprising synergic combinations of xyloglucans and plant or animal proteins, which are useful in the treatment of intestinal...
2017/0027979 METHOD FOR ASSESSING AND TREATING OR PREVENTING IMPAIRED PLASMA POLAR LIPID LEVELS
The invention pertains to the use of a preparation for the manufacture of a composition for preventing or treating impaired plasma levels of one or more polar...
2017/0027978 Cannabinoid Composition and Method For Treating Pain
A combination of THC, CBD and Cobalamin (in a ratio of about 63%, 27% and 10%, respectively) is used with a topical carrier such as Shea butter cream to...
2017/0027977 METHODS USEFUL IN THE PREVENTION OF HYPOXIC INJURY
Methods useful in the treatment of cytotoxic insults such as excitotoxic injury, ischemic injury, and hypoxic injury are disclosed. The methods involve the...
2017/0027976 NOVEL ADEMETIONINE FORMULATIONS
Provided herein are drinkable or edible compositions comprising ademetionine ("SAM-e" or "S-adenosyl-L-methionine"). Also provided herein are methods for...
2017/0027975 Methods of Treating Coronavirus Infection
The present invention provides methods for treating a coronavirus infection. For example, treatment may be effected by administering a neurotransmitter...
2017/0027974 MARIBAVIR ISOMERS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING
The invention relates to novel compositions and methods of using maribavir which enhance its effectiveness in medical therapy, as well as to maribavir isomers...
2017/0027973 MODULARION OF INVARIANT NATURAL KILLER T CELLS IN THE TREATMENT OF SEPSIS
The present disclosure is directed to the modulation of in variant Natural Killer T Cells (iNKT Cells) using a Th2-polarizing iNKT Cell agonist, such as an...
2017/0027972 Methods and Compositions for Treatment of Drug Addiction
Methods of reducing AMPA/NMDA ratio in D1-type medium spiny neurons (MSN) and/or reducing development of behavioural sensitization or suppressing drug induced...
2017/0027971 USE OF HDAC AND/OR DNMT INHIBITORS FOR TREATMENT OF ISCHEMIC INJURY
The present invention provides methods of ameliorating or reducing the extent of ischemic injury, reperfusion injury, and myocardial infarction, by...
2017/0027970 NEW COMPOUNDS AS POSITIVE ALLOSTERIC MODULATORS FOR ERYTHROPOIETIN AND ERYTHROPOIETIN RECEPTOR TO TREAT...
Disclosed are compounds which can act as a positive allosteric modulator for erythropoietin and erythropoietin receptor and have the activity in promoting...
2017/0027969 COMPOSITION CONTAINING GINSENOSIDE F1 FOR REMOVING AMYLOID PLAQUES
Provided are a food composition and a feed composition for removing amyloid plaques, each composition including ginsenoside F1, in which ginsenoside F1 is...
2017/0027968 ANTI-CANCER AGENT
The present invention provides an anti-cancer agent, a cancer cell death inducing agent, a protein phosphatase 2A activation enhancing agent, a protein...
2017/0027967 PHARMACEUTICAL FORMULATIONS
The invention provides a solid oral dosage form comprising rilpivirine or a pharmaceutically acceptable salt thereof, tenofovir alafenamide or a ...
2017/0027966 TUMOR ERADICATION BY INOSITOL-TRIPYROPHOSPHATE
The present invention relates to various salts of inositol tripyrophosphate including the calcium, lithium, beryllium, magnesium, potassium, strontium, barium,...
2017/0027965 CO-CRYSTALS OF TRAMADOL AND COXIBS
The present invention relates to co-crystals of tramadol and co-crystal formers selected from NSAIDs/coxibs, processes for preparation of the same and their...
2017/0027964 Method For Making Bismuth Containing Liquid Pharmaceutical Suspensions
A method of producing a liquid pharmaceutical suspension by mixing magnesium aluminum silicate, gellan gum, bismuth subsalicylate, and methyl cellulose.
2017/0027963 DELIVERY OF NON-STEROIDAL AGENTS TO THE BRAIN VIA THE NASAL TRACT TO TREAT NEUROLOGICAL DISORDERS
There is described a volatile form of an NSAID, and derivatives thereof, for use in the treatment of a neurological disorder. There is also described a method...
2017/0027962 METHODS AND COMPOUNDS FOR VITAMIN D THERAPY
Methods and compositions comprising 1,25-dihydroxyvitamin D.sub.2 are disclosed. A method for lowering or maintaining lowered serum parathyroid hormone in...
2017/0027961 COMPOSITIONS FOR THE TREATMENT OF CATARACTS
In one embodiment, the present application discloses an aqueous ophthalmic composition for the treatment of eye diseases, lesions and injuries, comprising: a)...
2017/0027960 INHALABLE MEDICAMENT
The present invention provides an inhalable pharmaceutical solution aerosol comprising beclometasone dipropionate, ethanol and a propellant selected from...
2017/0027959 NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE
The present invention relates to compounds and methods which may be useful as treatments of neuromuscular diseases such as muscular dystrophy, and as...
2017/0027958 FULVESTRANT COMPOSITIONS
The inventive subject matter provides ready to inject fulvestrant compositions with improved solubility and stability, and methods for preparing the same....
2017/0027957 METHODS AND COMPOSITIONS FOR TREATMENT OF PERIPHERAL NEUROPATHIES
A composition for therapy of a peripheral neuropathy disorder in a subject in need thereof. The composition comprises an effective amount of an agent selected...
2017/0027956 HETEROCYCLIC TYROSINE KINASE INHIBITORS
The present invention provides compounds useful as inhibitors of Tec family kinases, compositions thereof, and methods of using the same.
2017/0027955 EXPRESSION LEVELS OF BCL-XL, BCL2, BCL-W, AND BAD AND CANCER THERAPIES
Described herein are novel methods for treating subjects with a cancer which is not overexpressing at least one of BCL-xL, BCL-w, and BAD, and optionally...
2017/0027954 METHODS OF ENHANCING ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY
The application relates to method of increasing antibody-dependent cellular cytotoxicity in a subject receiving therapeutic monoclonal antibody treatment. In...
2017/0027953 QUINAZOLINES AND AZAQUINAZOLINES AS DUAL INHIBITORS OF RAS/RAF/MEK/ERK AND PI3K/AKT/PTEN/MTOR PATHWAYS
The present application provides novel quinazolines and azaquinazolines and pharmaceutically acceptable salts thereof. Also provided are methods for preparing...
2017/0027952 ASSOCIATION BETWEEN 3-[(3--2-OXO-2,3-DIHYDRO-1H-INDOL-5-YL)METHYL]-1,3-THIAZOLIDINE-2,4-DIONE AND AN EGFR...
Association between 3-[(3-{[4-(4-morpholinylmethyl)-1H-pyrrol-2-yl]methylene}-2-oxo-2,3-dihyd- ro-1H-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione of formula...
2017/0027951 METHODS AND COMPOSITIONS TO TREAT CANCERS INVOLVING EGFR
In one aspect, the invention relates to pharmaceutical compositions and methods for treating a cancer comprising administration of an EGFR inhibitor and a MEK...
2017/0027950 USE OF A PPAR-DELTA AGONIST FOR REDUCING LOSS OF MUSCLE STRENGTH, MUSCLE MASS, OR TYPE I MUSCLE FIBERS IN AN...
The present invention provides methods for reducing loss of muscle strength, muscle mass, or Type I muscle fibers in an immobilized limb by administering ...
2017/0027949 ASSOCIATION BETWEEN 8-CYCLOPROPYL-3-[2-(3-FLUOROPHENYL)ETHYL]-7,8-DIHYDRO-3H-[1,3]OXAZINO[6,5- ...
Association between 8-cyclopropyl-3-[2-(3-fluorophenyl)ethyl]-7,8-dihydro-3H-[1,3]-oxazino[6,- 5-g][1,2,3]benzotriazine-4,9-dione of formula (I): ...
2017/0027948 MACROCYCLIC COMPOUNDS AS ALK, FAK AND JAK2 INHIBITORS
The present invention provides compounds of Formula I ##STR00001## or a pharmaceutically acceptable salt forms thereof, wherein R1, R2, R3, R4, R5, A and X are...
2017/0027947 CHEWABLE LIPID SUPPLEMENTS CONTAINING CAFFEINE FOR INCREASING ALERTNESS, FOCUS AND ENERGY
Flavored chewable wafers containing caffeine suitable for increasing alertness and allow an individual to perform tasks in a more focused and energetic manner...
2017/0027946 SUBSTITUTED XANTHINE DERIVATIVES
This invention relates to novel compounds that are substituted xanthine derivatives and pharmaceutically acceptable salts thereof. For example, this invention...
2017/0027945 Novel Compounds
The present invention relates to a tris salt of 8-chloro-3-pentyl-3,7-dihydro-1H-purine-2,6-dione of Formula (A): ##STR00001## corresponding manufacture...
2017/0027944 METHODS FOR TREATING VIRAL DISORDERS
Disclosed are methods of treating viral disorders via the administration of an inducing agent and an anti-viral agent. In one embodiment, the inducing agent...
2017/0027943 Crystalline Forms of (s)-4-amino-n-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7h-pyrrolo[2,3-d]py- ...
The present invention discloses certain new solid state forms of (S)-4-amino-N-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7H-pyrrolo[2,3 ...
2017/0027942 TREATMENT OF ERECTILE DYSFUNCTION AND OTHER INDICATIONS
The present invention generally relates to the transdermal delivery of various compounds. In some aspects, transdermal delivery may be facilitated by the use...
2017/0027941 Bruton's Tyrosine Kinase Inhibitor Combinations and Uses Thereof
Disclosed are compositions, methods, and kits for treating a solid tumor comprising co-administering to an individual in need thereof a BTK inhibitor and an...
2017/0027940 METHOD FOR TREATING CANCER
The current disclosure relates to pharmaceutical combinations and compositions useful in the treatment of certain types of cancer. The disclosure also relates...
2017/0027939 Trk-INHIBITING COMPOUND
The present invention provides a drug containing a compound having Trk-inhibiting activity as an active ingredient in prophylaxis and/or therapy for...
2017/0027938 Combination
The present invention relates to a method of treating breast cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the...
2017/0027937 Heterocyclic Compounds and Uses Thereof
The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
2017/0027936 ABL1 INHIBITOR FOR TREATING AND PREVENTING OCULAR NEOVASCULARISATION
The present invention relates to an Abelson murine leukaemia viral oncogene homolog 1 (ABL1) inhibitor for use in the treatment of ocular neovascularisation...
2017/0027935 PRMT5 INHIBITORS AND USES THEREOF
Described herein are compounds of Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present...
2017/0027934 CERTAIN TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR
Provided are certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.
2017/0027933 Pharmaceutical Compositions
The present Invention relates to pharmaceutical compositions of (3S,11aR)--N-[(2,4-difluorophenyhmethyl]-2,3,5,7,11,11a-hexahydro-6-hydro- ...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.